We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Updated: 12/31/1969
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Updated: 12/31/1969
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Updated: 12/31/1969
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Blood Flow and Vascular Function in Cystic Fibrosis
Updated: 12/31/1969
Role of Blood Flow and Vascular Function on Exercise Capacity in Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Blood Flow and Vascular Function in Cystic Fibrosis
Updated: 12/31/1969
Role of Blood Flow and Vascular Function on Exercise Capacity in Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Updated: 12/31/1969
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Status: Enrolling
Updated: 12/31/1969
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Updated: 12/31/1969
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Updated: 12/31/1969
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Updated: 12/31/1969
A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease
Status: Enrolling
Updated: 12/31/1969
High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Updated: 12/31/1969
A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease
Updated: 12/31/1969
Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease
Status: Enrolling
Updated: 12/31/1969
Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease
Updated: 12/31/1969
Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD
Updated: 12/31/1969
A Prospective Randomized Controlled Trial to Evaluate the Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients Diagnosed With COPD
Status: Enrolling
Updated: 12/31/1969
Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD
Updated: 12/31/1969
A Prospective Randomized Controlled Trial to Evaluate the Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients Diagnosed With COPD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Updated: 12/31/1969
Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Status: Enrolling
Updated: 12/31/1969
Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Updated: 12/31/1969
Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Novartis Everolimus Transition
Updated: 12/31/1969
Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Novartis Everolimus Transition
Updated: 12/31/1969
Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)
Updated: 12/31/1969
Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Updated: 12/31/1969
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials